![Newspaper with an iPhone and iPad showing the news](https://birnbachcom.com/wp-content/uploads/2022/07/AdobeStock_49325735-1500x844.jpg)
- News Pub: “Hydrogen-rich gas inhalation can alleviate exercise-induced fatigue” (July 31, 2024)
- DVM360: “Global veterinary pharmaceutical specialist acquires innovative insulin programs” (July 31, 2024)
- Drug Development & Delivery: “Dechra Purchases Veterinary Insulin Programs From Akston Biosciences” (July 30, 2024)
- Morningstar: “Dechra Purchases Veterinary Insulin Programs from Akston Biosciences” (July 30, 2024)
- Marblehead Current: “News in Brief: PR Agencies Join Forces” (July 18, 2024)
- Head Topics: “Innovative home-based transcranial electrical stimulation training for older adults” (July 18, 2024)
- Health Medical Network: “Innovative home-based transcranial electrical stimulation training for older adults” (July 18, 2024)
- Morning News: “New training program facilitates home-based transcranial electrical stimulation” (July 17, 2024)
- News Medical: “Innovative home-based transcranial electrical stimulation training for older adults” (July 17, 2024)
- Reddit: “Innovative home-based transcranial electrical stimulation training for older adults” (July 17, 2024)
- Animal Health Corridor (via X): “@AHCorridor Exciting news! Dr. Linda Rhodes has joined Akston Biosciences’ Board of Directors. Dr. Rhodes is a past Iron Paw Honoree. Her contributions will be invaluable to the leadership of Akston. Congratulations Dr. Rhodes on your new venture! #AkstonBiosciences” (July 11, 2024)
- BullDog Reporter: “Birnbach Communications Expands Team, Deepens Expertise with KOGS Communication” (July 11, 2024)
- NewsCom: “Birnbach Communications Expands Team, Deepens Expertise with KOGS Communication” (July 10, 2024)
- Le Lezard: “Birnbach Communications Expands Team, Deepens Expertise with KOGS Communication” (July 10, 2024)
- The PharmaLetter: “Jason Tardio adds role at Immunic to impressive CV” (July 10, 2024)
- Mirage: “Research Links Vascular Dysfunction to Heart-Bone Health in Seniors” (July 10, 2024)
- Health Medical Network: “Study Investigates Vascular Dysfunction as Mechanism Underlying Link Between Heart and Bone Health in Older Adults” (July 10, 2024)
- BioWorld: “Appointments and advancements for July 9, 2024” (July 9, 2024)
- Associated Press: “Immunic Appoints Jason Tardio as Chief Operating Officer and President” (July 9, 2024)
- Contract Pharma: “Immunic Appoints Jason Tardio as COO and President: Tardio will lead internal efforts to prepare for the potential launch of vidofludimus calcium (IMU-838)” (July 9, 2024)
- Briefing.com: “Immunic announced that seasoned biopharmaceutical executive, Jason Tardio, will be joining the company as Chief Operating Officer and President, effective July 12, 2024” (July 9, 2024)
- Health Stock News: “Immunic Appoints Jason Tardio as COO and President” (July 9, 2024)
- M2 Pharma: “Immunic Appoints new chief operating officer and president” (July 9, 2024)
- TheFly: “Immunic Appoints Jason Tardio as COO” (July 9, 2024)
- Investing.com: “Immunic Appoints New COO and President” (July 9, 2024)
- Investing.com (Turkey) “Immunic Appoints New COO and President” (July 9, 2024)
- SogoTrade Research Center: “Immunic Appoints Jason Tardio as COO and President” (July 9, 2024)
- Crwe World (via X) “Immunic Appoints Jason Tardio as COO and President” (July 9, 2024)
- bio | tech | pharma stock scope (via X): “Immunic Appoints Jason Tardio as COO and President” (July 9, 2024)
- FirstWord Pharma: “Immunic Appoints Jason Tardio as COO and President” (July 9, 2024)
- BusinessFast: “How to do it … Budget-conscious security tech – McKnight’s Long-Term Care News” (July 9, 2024)
- McKnight’s Long-Term Care News: “How to do it … Budget-conscious security tech” (July 9, 2024)
- Marblehead Current: “Festival award winners announced” (July 4, 2024)
- Nutfield Times (Facebook): “A Tale of Friendship, Inspiration and the Gift of Life: Derry-resident Margaret’s journey to find a kidney” (July 2, 2024)